Clorox (NYSE:CLX) Price Target Raised to $137.00

Clorox (NYSE:CLX) had its target price raised by Barclays from $130.00 to $137.00 in a research report released on Friday morning, Benzinga reports. They currently have an underweight rating on the stock.

Several other equities analysts have also issued reports on the company. TD Cowen started coverage on Clorox in a research report on Tuesday, July 23rd. They set a sell rating and a $122.00 target price for the company. Jefferies Financial Group upgraded Clorox from a hold rating to a buy rating and boosted their target price for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft boosted their price objective on Clorox from $144.00 to $151.00 and gave the company a hold rating in a research report on Friday, August 2nd. Citigroup boosted their price objective on Clorox from $165.00 to $170.00 and gave the company a neutral rating in a research report on Friday, September 6th. Finally, Wells Fargo & Company decreased their price objective on Clorox from $135.00 to $130.00 and set an underweight rating for the company in a research report on Wednesday, July 10th. Six investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of Hold and a consensus price target of $150.36.

Clorox Stock Performance

Shares of NYSE:CLX opened at $160.30 on Friday. The stock has a market capitalization of $19.91 billion, a P/E ratio of 83.06, a P/E/G ratio of 3.19 and a beta of 0.41. Clorox has a 1-year low of $114.68 and a 1-year high of $169.09. The business has a 50-day moving average price of $157.36 and a two-hundred day moving average price of $144.72. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. The company had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a return on equity of 281.12% and a net margin of 3.95%. Equities analysts predict that Clorox will post 6.64 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.04%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.51% of the company’s stock.

Institutional Investors Weigh In On Clorox

A number of institutional investors and hedge funds have recently made changes to their positions in CLX. V Square Quantitative Management LLC raised its stake in shares of Clorox by 128.3% during the 4th quarter. V Square Quantitative Management LLC now owns 4,629 shares of the company’s stock worth $660,000 after purchasing an additional 2,601 shares in the last quarter. Integrated Advisors Network LLC raised its stake in Clorox by 15.1% in the 4th quarter. Integrated Advisors Network LLC now owns 3,338 shares of the company’s stock valued at $476,000 after acquiring an additional 437 shares during the period. Syon Capital LLC bought a new stake in Clorox in the 4th quarter valued at $284,000. EP Wealth Advisors LLC raised its stake in Clorox by 4.0% in the 4th quarter. EP Wealth Advisors LLC now owns 6,810 shares of the company’s stock valued at $971,000 after acquiring an additional 263 shares during the period. Finally, Richardson Financial Services Inc. bought a new stake in Clorox in the 4th quarter valued at $51,000. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.